Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Diabetic Macular Edema
Related studies linked through entity extraction aliases.
A Phase I Single Ascending Dose Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With DME
- Status
- COMPLETED
- Phase
- PHASE1
Retrospective Trial on the Efficacy and Safety of Intravitreal Ozurdex in Patients With Diabetic Macular Edema.
- Status
- COMPLETED
- Phase
- N/A
Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Performance Assessment Tests in Working Individuals With DME Following Treatment With Ranibizumab
- Status
- COMPLETED
- Phase
- PHASE4
A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME)
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE4
Relating Retinal Structural and Functional Parameters to Visual Acuity in Eyes Undergoing Treatment for Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- N/A
Reading Center - Occurence of Diabetic Macular Edema in Patients With Diabetes Mellitus in Slovak Republic
- Status
- UNKNOWN
- Phase
- N/A
Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular Edema
- Status
- UNKNOWN
- Phase
- PHASE4
Retinal Ganglion Cell Function After Intravitreous Ranibizumab in Patients With Diabetic Macular Edema
- Status
- WITHDRAWN
- Phase
- PHASE4
Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety Study to Evaluate Two Doses of Oral DMI-5207 in Adult Subjects With Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE2
Outcomes of Diabetic Macula Edema Patients Switched to Aflibercept From Bevacizumab and/or Ranibizumab
- Status
- COMPLETED
- Phase
- N/A
Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular ("Wet") Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME)
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Ranibizumab for Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular Diseases
- Status
- UNKNOWN
- Phase
- PHASE2
Diabetic Macular Edema Treated With Ozurdex (DMEO)
- Status
- COMPLETED
- Phase
- PHASE2
Characterization of Eyes With Diabetic Macular Edema That Show Different Treatment Response to Intravitreal Anti-VEGF (CHARTRES)
- Status
- COMPLETED
- Phase
- N/A
Phase II Combination Steroid and Anti-VEGF for Persistent DME
- Status
- COMPLETED
- Phase
- PHASE2